WHO ICTRP trial

Increased incidence of type 2 diabetes and cardiovascular disease in Hindostani…

NL-OMON38272 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting

Key facts

Trial ID NL-OMON38272
Public title Increased incidence of type 2 diabetes and cardiovascular disease in Hindostani as compared to Caucasians: role of intracellular pathways leading to glucose uptake and mitochondrial function on ectopic fat storage.
Scientific title Increased incidence of type 2 diabetes and cardiovascular disease in Hindostani as compared to Caucasians: role of intracellular pathways leading to glucose uptake and mitochondrial function on ectopic fat storage. - Pathofysiology of type 2 diabetes and CVD in Hindostani versus Caucasians
Primary sponsor Leids Universitair Medisch Centrum
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Recruiting
Study type Interventional
Countries Netherlands
Conditions insulin resistance sugar disease;10018424;insulin resistance;sugar disease
Interventions Study 1 1 week highcaloric/hig fat feeding in the young group: 140% of energy needs (calculated with the Harris-Benedict equation) with the extra 40% in the form of 2 snacks per day amounting 50%, 40% and 10% of energy of fat, carbohydrate…
Registration date Dec 5, 2012
Target size 72
Secondary IDs NL26733.058.09
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations